This invention discloses
terpenoid compounds with anticancer activity and their preparation methods, belonging to the field of
biotechnology. The invention employs a chemical-enzymatic method, first chemically synthesizing the natural
substrate analog 7-O-FPP, and then using the
sesquiterpene synthase TmS for
in vitro catalysis to obtain three
oxygen-containing
sesquiterpene products. MTT activity assays showed that the three compounds exhibited significant anticancer activity against gastric
cancer SGC7901,
lung cancer NCI-H1975,
cervical cancer HeLa, and
esophageal squamous cell carcinoma KYSE-150 cells. Compounds 1 and 3 showed anticancer activity against various
cancer cell lines. 50 The concentration of compounds below 1 μg / mL showed significantly superior activity compared to the clinical
drug β-
elemene; compound 2 exhibited higher activity against
lung cancer cells and
low toxicity to normal MRC-5 cells. This invention provides an efficient method for preparing novel
terpenoid compounds, and the resulting compounds offer high-quality lead molecules for the development of new anticancer drugs, demonstrating promising application prospects.